nAngioDerm participated in world congress TERMIS

Professor Elisabeth Engel from IBEC, coordinator of nAngioDerm European project, presented the advances of the project at the 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS2021). Professor Engel talked about cells-materials interactions to promote vascularization in one of the most important scientific conferences in the field of tissue engineering and regenerative medicine.

Last advances of European nanomedicine against malaria explained in a new video

Malaria kills over 500,000 people every year. In the last three years, researchers within the NANOpheles Project worked on the development of nanovectors targeting Plasmodium parasites in the mosquito vector. Xavier Fernàndez-Busquets, coordinator of the EU-funded project, explains their advances in a new video.

Researchers discover how cellular membranes change curvature depending on BAR proteins

A team of researchers at IBEC and UPC, led by Pere Roca-Cusachs and Marino Arroyo, study how BAR proteins, a family of molecules that bind curved cellular membranes, reshape these membranes. Scientists report in the journal Nature Communications, through both experiments and modelling, the dynamics of these membrane reshaping processes that occur both in normal cells or disease scenarios.

IBEC promotes the development of advanced therapies thanks to FEDER funding

Funding from the 2014-2020 Catalan FEDER Operational Program, through the call for institutional projects for R+D infrastructure with a total amount of 700,000€, has co-financed the adaptation of new laboratory spaces and the acquisition of scientific equipment for IBEC laboratories. These new infrastructures will be aimed at boosting nanomedicine and tissue engineering research for the development of advanced therapies.

Bioengineering against COVID-19 receives a new boost thanks to “La Marató”

Three projects of the Institute for Bioengineering of Catalonia (IBEC) will receive funding from “La Marató de TV3” to investigate different aspects of COVID-19. Thanks to the contributions received, the experts will deepen their understanding of the disease and its possible therapeutic solutions, study improvements in patient care processes, develop a system to predict the evolution of the respiratory system, and advance in the treatment of patients with pneumonia derived from COVID19.